References
- Borse V, Konwar AN, Buragohain P. Oral cancer diagnosis and perspectives in India. Sens Int. 2020;1:100046.
- Inchingolo F, Santacroce L, Ballini A, et al. Oral Cancer: A Historical Review. Int J Environ Res Public Health. 2020;17(9):3168.
- Geiger JL, Grandis JR, Bauman JE. The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations. Oral Oncol. 2016;56:84-92.
- Yu H, Lee H, Herrmann A, Buettner R, Jove R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer. 2014;14(11):736-746. doi:10.1038/nrc3818
- Wang X, Zhang X, Qiu C, Yang N. STAT3 Contributes to Radioresistance in Cancer. Front Oncol. 2020;10:1120.
- Yoshida R, Fujimoto T, Kudoh S, et al. Nucleostemin affects the proliferation but not differentiation of oral squamous cell carcinoma cells. Cancer Sci. 2011;102(7):1418-1423.
- Macha MA, Matta A, Kaur J, et al. Prognostic significance of nuclear pSTAT3 in oral cancer. Head Neck. 2011;33(4):482-489. doi:10.1002/ hed.21468
- Cada Z, Boucek J, Dvoranková B, et al. Nucleostemin expression in squamous cell carcinoma of the head and neck. Anticancer Res. 2007;27(5A):3279-3284.
- Pederson T, Tsai RY. In search of nonribosomal nucleolar protein function and regulation. J Cell Biol. 2009;184(6):771-776.